首页> 美国卫生研究院文献>Translational Psychiatry >Novel primate-specific PDE10A isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder
【2h】

Novel primate-specific PDE10A isoform highlights gene expression complexity in human striatum with implications on the molecular pathology of bipolar disorder

机译:新颖的灵长类动物特异性PDE10A亚型突显了人类纹状体中基因表达的复杂性并影响了躁郁症的分子病理学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bipolar disorder is a highly heritable neuropsychiatric disorder affecting nearly 2.5% of the population. Prior genetic studies identified a panel of common and rare single-nucleotide polymorphisms associated with the disease that map to the first intron of the PDE10A gene. RNA sequencing of striatal brain tissue from bipolar and healthy control subjects identified a novel transcript of PDE10A, named PDE10A19, that codes for a PDE10A isoform with a unique N terminus. Genomic sequences that can encode the novel N terminus were conserved in other primates but not rodents. The RNA transcript was expressed at equal or greater levels in the human striatum compared with the two annotated transcripts, PDE10A1 and PDE10A2. The PDE10A19 transcript was detected in polysomal fractions; western blotting experiments confirmed that the RNA transcript is translated into protein. Immunocytochemistry studies using transfected mouse striatal and cortical neurons demonstrated that the PDE10A19 protein distributes to the cytosol, like PDE10A1, and unlike PDE10A2, which is associated with plasma membranes. Immunoprecipitation and immunocytochemical experiments revealed that the PDE10A19 isoform interacts physically with PDE10A2 and, when expressed at elevated levels, interferes with the plasma membrane localization of PDE10A2. These studies illustrate the complexity of PDE10A gene expression in the human brain and highlight the need to unravel the gene's complex and complete coding capabilities along with its transcriptional and translational regulation to guide the development of therapeutic agents that target the protein for the treatment of neuropsychiatric illness.
机译:躁郁症是一种高度遗传的神经精神病,影响了近2.5%的人口。先前的遗传研究确定了与该疾病相关的一组常见和罕见的单核苷酸多态性,这些多态性对应于PDE10A基因的第一个内含子。来自双相和健康对照对象的纹状体脑组织的RNA测序鉴定了一种名为PDE10A19的PDE10A新型转录本,该转录本编码具有唯一N端的PDE10A亚型。可以编码新的N末端的基因组序列在其他灵长类动物中是保守的,但在啮齿动物中却不保守。与两个带注释的转录本PDE10A1和PDE10A2相比,RNA转录本在人纹状体中表达的水平相同或更高。在多体部分中检测到PDE10A19转录本;免疫印迹实验证实,RNA转录物被翻译成蛋白质。使用转染的小鼠纹状体和皮层神经元进行的免疫细胞化学研究表明,PDE10A19蛋白像PDE10A1一样分布在细胞质中,与PDE10A2不同,后者与质膜有关。免疫沉淀和免疫细胞化学实验表明,PDE10A19同工型与PDE10A2发生物理相互作用,并在高水平表达时会干扰PDE10A2的质膜定位。这些研究说明了PDE10A基因在人脑中表达的复杂性,并强调了需要揭示该基因复杂而完整的编码能力以及其转录和翻译调控,以指导靶向该蛋白的治疗剂的开发,以治疗神经精神疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号